通威股份(600438.SH):通威太陽能擬120億元投建年產32GW高效晶硅電池項目
格隆匯3月31日丨通威股份(600438.SH)公佈,為進一步擴大公司在高效晶硅電池產業的規模優勢,推動實現公司戰略發展目標,公司旗下通威太陽能擬與四川天府新區眉山管理委員會簽署《投資協議》,在眉山天府新區青龍街道投資建設32GW高效晶硅電池項目。項目分兩期實施,總投資預計120億元。其中一期16GW電池項目投資約60億元,力爭於2023年12月底前投產,二期16GW電池項目將根據協議約定擇機啟動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.